Search results for "lung cancer"

FCS Real-World Evidence Abstract Highlights Progress and Gaps in Biomarker Testing for Lung Cancer

FCS physician, Rami Owera, MD co-authors MYLUNG study findings highlighting advances and ongoing gaps in biomarker testing for lung cancer care. Read More

FCS Phase 3 Trial Demonstrates Initial Clinical Benefit of Novel Immunotherapy For Advanced Non-Small Cell Lung Cancer

FCS contributes to PRESERVE-003 findings showing gotistobart may improve outcomes in metastatic NSCLC. Read More

Immunotherapy Treatments for Lung Cancer

Immunotherapy has emerged as a treatment option for lung cancer, offering new hope to many patients. Learn More. Read More

Lung Cancer - Summary, Symptoms, Treatments

Get the facts on lung cancer. Learn about its causes, symptoms, and how to take steps for early detection. Read More

Small Cell Lung Cancer Treatment

Discover the latest advancements in small cell lung cancer treatment. Learn about innovative therapies and strategies to improve patient outcomes. Read More

Lung Cancer Screening

Stay proactive about your health with lung cancer screening. Find out why this test is essential for early detection and increasing survival rates. Read More

Non-Small Cell Lung Cancer Treatment

Stay informed about the latest treatments for Non-Small Cell Lung Cancer. Find out about innovative therapies and advancements in cancer care. Read More

New Clinical Study Identifies Personalized Treatment Options for Metastatic Non-Small Cell Lung Cancer With Plasma Proteome Testing

A clinical study co-authored by Ernesto Bustinza-Linares, MD has found that proteome testing leads to targeted treatment for NSCLC. Read More

New Treatment Minimizes Side Effects of Chemotherapy for Lung Cancer Patients

Research conducted by FCS confirmed the effectiveness of a new medication in protecting bone marrow of patients who receive chemotherapy for small cell lung cancer. Read More

Clinical Research Demonstrates Positive Impact of Genomic Testing for Patients with Non-small Cell Lung Cancer

Molecular testing results prior to beginning first-line treatment for non-small cell lung cancer (NSCLC) appear to live longer. Read More